Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy

NCT: NCT07473648 · RECRUITING

NCT IDNCT07473648
StatusRECRUITING
Start Date2025-09-01
Completion2028-01
SponsorThe Second Hospital of Anhui Medical University (OTHER)
First posted
Last updated

Brief Summary

To compare the efficacy and tolerability of Electroconvulsive Therapy (ECT) and Magnetic Seizure Therapy (MST) in patients with major depressive disorder (MDD).

Frequently Asked Questions

What is Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy?

Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy is a clinical trial registered under NCT07473648. Current status: RECRUITING.

What is the status of NCT07473648?

The current status of NCT07473648 (Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy) is: RECRUITING.

When did Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy start?

Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy started on 2025-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑